04633nam 2200613 a 450 991078147070332120230802004228.01-283-31755-997866133175511-61705-019-9(CKB)2550000000063677(EBL)787865(OCoLC)758334168(SSID)ssj0000539475(PQKBManifestationID)12232431(PQKBTitleCode)TC0000539475(PQKBWorkID)10585211(PQKB)11297638(MiAaPQ)EBC787865(Au-PeEL)EBL787865(CaPaEBR)ebr10509680(CaONFJC)MIL331755(EXLCZ)99255000000006367720110608d2012 uy 0engur|n|---|||||txtccrNeurologic complications of cancer therapy[electronic resource] /[edited by] Patrick Y. Wen, David Schiff, Eudocia C. QuantNew York demos Medicalc20121 online resource (439 p.)Description based upon print version of record.1-936287-07-2 Includes bibliographical references and index.Neurologic complications of alkylating agent chemotherapy / Herbert B. Newton -- Neurologic complications of antimetabolites / Ryan Merrell, Jorg Dietrich, and Tracy Batchelor -- Neurologic complications associated with plant alkaloids / Abhishek Singla, Aditya Bardia, and Vinay Chaudhry -- Neurologic complications of topoisomerase inhibitors / April F. Eichler -- Neurologic complications of epothilones and amino acid degraders / April F. Eichler -- Neurologic complications of corticosteroids / Erin M Dunbar, Rizwan Kalani, and Santosh Kesari -- Neurologic complications of immunomodulatory agents / Stuart C. Apfel -- Neurologic complications of immunosuppressive drugs / Ramani Balu and Amy A.Pruitt -- Neurologic complications associated with biologic agents / Aaron G. Mammoser and Morris D. Groves -- Neurologic complications of targeted therapy / Eudocia C. Quant ... [et al.] -- Neurologic complications of hormonal chemotherapies / Wendy Sherman Sojka and Jeffrey Raizer -- Neurologic complications associated with supportive therapies / Jan Drappatz -- Chemotherapy-associated cognitive dysfunction / Jorg Dietrich and Alexander Pine -- Central nervous system toxicity of chemotherapy / Jerome J. Graber and Lisa M. DeAngelis -- Neurologic complications affecting peripheral nerves / Guido Cavaletti and Paola Marmiroli -- Neurologic complications affecting muscles and the neuromuscular junction / Kelly G. Gwathmey, Ted M. Burns, and Elliot L. Dimberg -- Cellular mechanisms of radiation injury to cognition / Michelle Monje -- Central nervous system complications of radiation therapy / Damien Ricard ... [et al.] -- Radiation-induced tumors / Hilary L. Somerset, B.K. Kleinschmidt-DeMasters, and Kevin O. Lillehei -- Radiation vasculopathy / Lisa R. Rogers -- Radiation myelopathy / Timothy E. Schultheiss -- Radiation-induced peripheral nerve disorders / Odysseas Kargiotis and Athanasios P. Kyritsis -- Complications of neurosurgical oncology / Brian J. Williams, Robert G. Louis, and Mark E. Shaffrey -- Neurologic complications of hematopoietic stem cell transplantation / Eudocia C. Quant and Patrick Y. Wen.Neurologic side effects of cancer therapy can inhibit treatment, can be dose-limiting and can diminish quality-of-life. Neurotoxicity related to cancer therapy is a common problem in oncology practice and in clinical neurology. Recognition of neurologic complications of anticancer therapy is necessary due to potential confusion with metastatic disease, paraneoplastic syndromes or comorbid neurologic disorders that do not require reduction or discontinuation of therapy. Neurologic Complications of Cancer Therapy provides comprehensive coverage of the recognition and management of neurologic symCancerTreatmentComplicationsCancerTreatmentNeurologic manifestations of general diseasesCancerTreatmentComplications.CancerTreatment.Neurologic manifestations of general diseases.616.99/406Wen Patrick Y1567381Schiff David1959-967491Lee Eudocia Quant1567382MiAaPQMiAaPQMiAaPQBOOK9910781470703321Neurologic complications of cancer therapy3838773UNINA